William V. Murray

2.7k citations

100 papers · 2.3k indexed · h-index 27

Impact in

Organic Chemistry top 1%
- Synthesis and biological activity
- Catalytic C–H Functionalization Methods
- Catalytic Cross-Coupling Reactions
- Synthesis and Biological Evaluation
- Multicomponent Synthesis of Heterocycles
- Synthetic Organic Chemistry Methods
- Asymmetric Synthesis and Catalysis
Molecular Biology top 10%
- Chemical Synthesis and Analysis

Papers in

Organic Chemistry 57
- Synthetic Organic Chemistry Methods 13
- Asymmetric Synthesis and Catalysis 10
- Carbohydrate Chemistry and Synthesis 8
- Organic Chemistry Cycloaddition Reactions 7
- Synthesis and biological activity 6
Toxicology 3

Co-authors: Fu‐An Kang Zhihua Sui Gee‐Hong Kuo Sigmond G. Johnson Keith T. Demarest Linda K. Jolliffe Peter J. Connolly Lawrence J. Wilson
Journals: Bioorganic & Medicinal Chemistry Letters (34 papers)Tetrahedron Letters (15 papers)The Journal of Organic Chemistry (12 papers)Journal of Medicinal Chemistry (11 papers)Bioorganic & Medicinal Chemistry (4 papers)
Partner nations: United States Norway Belgium

In The Last Decade

William V. Murray

98 papers receiving 2.2k citations

Peers

Countries citing papers authored by William V. Murray

Since Specialization

Citations

This map shows the geographic impact of William V. Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William V. Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William V. Murray more than expected).

Fields of papers citing papers by William V. Murray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William V. Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William V. Murray. The network helps show where William V. Murray may publish in the future.

Co-authorship network

The 25 scholars most cited alongside William V. Murray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with William V. Murray Line = papers co-authored together William V. Murray links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Synthesis and biological evaluation of benzocyclobutane-C-glycosides as potent and orally active SGLT1/SGLT2 dual inhibitors Bioorganic & Medicinal Chemistry Letters ·Gee‐Hong Kuo, Micheal D. Gaul, Yin Liang, June Xu, Fuyong Du, Pamela J. Hornby, Guozhang Xu, Jenson Qi, Nathaniel Wallace, Seung‐Hun Lee, Eugene B. Grant, William V. Murray, Keith T. Demarest	2018	29
2	Discovery of N-arylpyrroles as agonists of GPR120 for the treatment of type II diabetes Bioorganic & Medicinal Chemistry Letters ·Michael P. Winters, Zhihua Sui, Mark J. Wall, Yuanping Wang, Joseph W. Gunnet, James Leonard, Hong Hua, Wen Yan, Arthur T. Suckow, 吕宗涛, Nuanprae Kitisin, Hyun Ji Koo, А. V. Ignatenko, Tatiana Koudriakova, Norman Huebert, William V. Murray	2018	18
3	4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable stearoyl-CoA desaturase-1 (SCD1) inhibitors: Part 2. Pyridazine-based analogs Bioorganic & Medicinal Chemistry Letters ·Shyh‐Ming Yang, Yuting Tang, Thomas A. Rano, Erin Elizabeth Marie Sweeney, Gee‐Hong Kuo, Michael D. Gaul, Yaxin Li, Elmer Jay Brown, Wensheng Lang, James G. Conway, Yin Liang, James M. Lenhard, Keith T. Demarest, William V. Murray	2014	6
4	Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy Bioorganic & Medicinal Chemistry Letters ·Lawrence J. Wilson, Bingbing Wang, Angeline Shak. Tzeyung, Robert H. Scannevin, Sharon L. Burke, Prabha Karnachi, Kenneth J. Rhodes, William V. Murray	2011	7
5	Synthesis and discovery of 2,3-dihydro-3,8-diphenylbenzo[1,4]oxazines as a novel class of potent cholesteryl ester transfer protein inhibitors Bioorganic & Medicinal Chemistry Letters ·Aihua Wang, Catherine Prouty, Patricia D. Pelton, E. G. Santarelli, Keith T. Demarest, William V. Murray, Gee‐Hong Kuo	2010	34
6	Discovery and SAR of para-alkylthiophenoxyacetic acids as potent and selective PPARδ agonists Bioorganic & Medicinal Chemistry Letters ·Rui Zhang, Daiane Correia Vasconcelos, Aihua Wang, Ellen Sieber-McMaster, Xun Li, Ronald K. Russell, Patricia D. Pelton, Jun Xu, Peifen Zhu, Lubing Zhou, Keith T. Demarest, William V. Murray, Gee‐Hong Kuo	2009	8
7	Synthetic staurosporines via a ring closing metathesis strategy as potent JAK3 inhibitors and modulators of allergic responses Bioorganic & Medicinal Chemistry Letters ·Lawrence J. Wilson, Ravi Malaviya, Світлана Аркадіївна Карпова, Rochelle L. Argentieri, Bingbing Wang, Xin Chen, William V. Murray, Druie Cavender	2009	14
8	Synthesis and structure–activity relationship of 7-azaindole piperidine derivatives as CCR2 antagonists Bioorganic & Medicinal Chemistry Letters ·Mingde Xia, Cuifen Hou, Duane E. DeMong, Scott R. Pollack, Meng Pan, Monica Singer, R. Hilsch, William V. Murray, Druie Cavender, Michael P. Wachter	2008	14
9	Synthesis and structure–activity relationships of thiadiazole-derivatives as potent and orally active peroxisome proliferator-activated receptors α/δ dual agonists Bioorganic & Medicinal Chemistry ·Lan Shen, Yan Zhang, Aihua Wang, Ellen Sieber-McMaster, Xiaoli Chen, Patricia D. Pelton, June Xu, Maria Yang, Peifen Zhu, Lubing Zhou, Michael Reuman, Maria Teope, Ronald K. Russell, Alan C. Gibbs, Charles O Taylor, Keith T. Demarest, William V. Murray, Gee‐Hong Kuo	2007	21
10	Discovery of para-alkylthiophenoxyacetic acids as a novel series of potent and selective PPARδ agonists Bioorganic & Medicinal Chemistry Letters ·Rui Zhang, Aihua Wang, Daiane Correia Vasconcelos, Patricia D. Pelton, Jun Xu, Peifen Zhu, Lubing Zhou, Keith T. Demarest, William V. Murray, Gee‐Hong Kuo	2007	23
11	β-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: Part 1. Design, synthesis, and lead identification Bioorganic & Medicinal Chemistry Letters ·Angeline Shak. Tzeyung, Robert H. Scannevin, Bingbing Wang, Sharon L. Burke, Lawrence J. Wilson, Prabha Karnachi, Kenneth J. Rhodes, Bharat Lagu, William V. Murray	2007	24
12	Simplified staurosporine analogs as potent JAK3 inhibitors Bioorganic & Medicinal Chemistry Letters ·Angeline Shak. Tzeyung, Ravi Malaviya, Lawrence J. Wilson, Rochelle L. Argentieri, Xin Chen, Світлана Аркадіївна Карпова, Bingbing Wang, Druie Cavender, William V. Murray	2006	63
13	3-Acyl-2,6-diaminopyridines as cyclin-dependent kinase inhibitors: synthesis and biological evaluation Bioorganic & Medicinal Chemistry Letters ·Ronghui Lin, Yanhua Lü, Steven K. Wetter, Peter J. Connolly, Ignatius J. Turchi, William V. Murray, Stuart L. Emanuel, Robert H. Gruninger, Angel R. Fuentes‐Pesquera, Mary Adams, Niranjan B. Pandey, ALESSANDRA GENU DUTRA AMARAL, Steven A. Middleton, Linda K. Jolliffe	2005	21
14	Design, synthesis, and biological evaluation of novel 7-azaindolyl-heteroaryl-maleimides as potent and selective glycogen synthase kinase-3β (GSK-3β) inhibitors Bioorganic & Medicinal Chemistry ·David J. O’Neill, Lan Shen, Catherine Prouty, Barbara R. Conway, Lori Westover, Jun Xu, Han‐Cheng Zhang, Bruce E. Maryanoff, William V. Murray, Keith T. Demarest, Gee‐Hong Kuo	2004	41
15	Synthesis and evaluation of nonpeptide substituted spirobenzazepines as potent vasopressin antagonists Bioorganic & Medicinal Chemistry Letters ·篤史内田, Robert H. Chen, Keith T. Demarest, Joseph W. Gunnet, Richard Look, William Hageman, William V. Murray, Donald W. Combs, Philip J. Rybczynski, Mona Patel	2004	4
16	2,5-Disubstituted 3,4-dihydro-2H-benzo[b][1,4]thiazepines as potent and selective V2 arginine vasopressin receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Ellen, Robert H. Chen, Keith T. Demarest, Joseph W. Gunnet, Richard Look, Francisco de n. 1497 Jerez, William V. Murray, Philip J. Rybczynski, Xiaoyan Zhang	2003	32
17	Arylpiperazine substituted heterocycles as Selective α1a adrenergic antagonists Bioorganic & Medicinal Chemistry Letters ·Haripada Khatuya, R. H. Hutchings, Gee‐Hong Kuo, Virginia Pulito, Linda K. Jolliffe, Xiaobing Li, William V. Murray	2002	11
18	Novel heterocycles as selective α1-adrenergic receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Xiaobing Li, Vincent LUBANZA NTITA, William V. Murray, Linda K. Jolliffe, Virginia Pulito	2000	6
19	1,3-Diarylcycloalkanopyrazoles and diphenyl hydrazides as selective inhibitors of cyclooxygenase-2 Bioorganic & Medicinal Chemistry Letters ·Zhihua Sui, Mannor, Metin Tolan, Kathy D. McCoy, Michael P. Wachter, William V. Murray, Monica Singer, Avinash Gohilot, Jun Wang, Dennis Argentieri	2000	72
20	Novel arylpiperazines as selective α 1 -adrenergic receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Xiaobing Li, William V. Murray, Linda K. Jolliffe, Virginia Pulito	2000	12

About William V. Murray

William V. Murray is a scholar working on Organic Chemistry, Toxicology, Molecular Biology, Endocrinology, Diabetes and Metabolism and Biochemistry, having authored 100 papers that have together received 2.3k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (14 papers), Receptor Mechanisms and Signaling (14 papers), Synthetic Organic Chemistry Methods (13 papers), Asymmetric Synthesis and Catalysis (10 papers), Neuropeptides and Animal Physiology (8 papers), Carbohydrate Chemistry and Synthesis (8 papers), Organic Chemistry Cycloaddition Reactions (7 papers) and Synthesis and biological activity (6 papers). The work is most often cited by research in Organic Chemistry (1.6k citations), Molecular Biology (894 citations), Toxicology (42 citations), Pharmaceutical Science (68 citations) and Pharmacology (164 citations). William V. Murray has collaborated with scholars based in United States, Norway and Belgium. Frequent co-authors include Fu‐An Kang, Zhihua Sui, Gee‐Hong Kuo, Sigmond G. Johnson, Keith T. Demarest, Linda K. Jolliffe, Peter J. Connolly, Lawrence J. Wilson, Michael P. Wachter and Steven A. Middleton. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Tetrahedron Letters, The Journal of Organic Chemistry, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact